医学
系统回顾
病态的
骨软化症
医学文献
梅德林
放射性武器
放射科
外科
病理
骨质疏松症
政治学
法学
作者
Dingbang Chen,Luosheng Zhang,Jilei Zhang,Mengchen Yin,Xin Gao,Quan Huang,Linfeng Li,Xinhai Yang
标识
DOI:10.1016/j.wneu.2024.01.032
摘要
Spinal phosphaturic mesenchymal tumor (PMT) is a rare disorder but can be cured once the diagnosis is clear and a complete removal by surgery is performed. To the best of our knowledge, only 22 cases in the spine have been described, and we report a case with the largest number of spinal segments (T12-L5) affected among spine PMT cases. A comprehensive literature search was performed until May 23, 2023, following the Preferred Reporting Items for Systematic Reviews guidelines. Studies were chosen through relevant PubMed, Web of Science, and EMBASE searches to prioritize obtaining the largest studies. The Medical Subject Headings and Boolean operators employed for this search were (“PMT” or “TIO” or “Tumor-induced osteomalacia” or “phosphaturic mesenchymal tumor”) and (“spine” or “spinal”). Two researchers (L.S.Z. and D.B.C) independently reviewed and evaluated the included articles. Any differing opinions were discussed until a consensus was reached. A total of 18 studies were included. A case report is also presented. We report a case of spinal PMT. The full text of the relevant articles was construed. A total of 18 studies were reviewed and consolidated. These articles are roughly divided into the following five subcategories: (1) clinical features and baseline distribution, (2) laboratory and imaging findings, (3) pathological manifestations, and (4) surgical methods and treatment options. Spinal PMT is very rare with a high rate of misdiagnosis and debilitating complications, so it is of significance to increase awareness of the disease among spine surgeons consulted by patients with spinal PMT. 68Ga-DOTATOC-PET/CT shows very high sensitivity to the spinal PMT but there is no way to exactly determine the location of the tumor. PMT has unique immunohistochemical characteristics and malignant PMT is rare. Once diagnosed, complete surgical excision is the recommended treatment. Burosumab is one of the available options, especially in cases that are recurrent and difficult to surgically resect.
科研通智能强力驱动
Strongly Powered by AbleSci AI